YQ23 Study in Patients With Critical Limb Ischaemia

NCT04792008 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Due to business decision

Conditions

Critical Limb Ischemia

Interventions

BIOLOGICAL: YQ23
BIOLOGICAL: Matching placebo

Sponsor

New Beta Innovation Limited